Patents Assigned to SPR Therapeutics, LLC
-
Patent number: 11540973Abstract: A system and method of using a lead introduced to a subject proximate to a region of pain is contemplated to deliver pain relief without the need for multiple needle insertions or electrical stimulation. The three-dimensional lead may include spring-like characteristics and/or coils to translate mechanical energy into the therapy.Type: GrantFiled: October 23, 2017Date of Patent: January 3, 2023Assignee: SPR Therapeutics, LLCInventors: Meredith McGee, Nathan Crosby, John Chae, Joseph W. Boggs
-
Patent number: 9827412Abstract: Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.Type: GrantFiled: July 5, 2016Date of Patent: November 28, 2017Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, John Chae
-
Patent number: 9827419Abstract: Neurostimulation assemblies, systems, and methods make possible the providing of short-term therapy or diagnostic testing by providing electrical connections between muscles and/or nerves inside the body and stimulus generators and/or recording instruments mounted on the surface of the skin or carried outside the body. The assembly affords maximum patient mobility and comfort through differentiated components having minimal profiles and connected by way of detachable and adjustable connections.Type: GrantFiled: November 27, 2015Date of Patent: November 28, 2017Assignee: SPR Therapeutics, LLCInventors: Joseph W. Boggs, II, Robert B. Strother, Kathryn W. Stager, Jonathan L. Sakai, Amorn Wongsarnpigoon, Matthew deBock, Devin Sell, Meredith McGee
-
Patent number: 9707394Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: GrantFiled: February 1, 2016Date of Patent: July 18, 2017Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae
-
Patent number: 9616229Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: GrantFiled: July 21, 2014Date of Patent: April 11, 2017Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae
-
Patent number: 9555245Abstract: It has been discovered that pain felt in a given region of the body can be treated by stimulating a peripheral nerve at a therapeutically effective distance from the region where pain is felt to generate a comfortable sensation (i.e., paresthesia) overlapping the regions of pain. A method has been developed to reduce pain in a painful region following limb joint replacement by stimulating a peripheral nerve innervating the painful region with an electrode inserted into tissue and spaced from the peripheral nerve. This method may be used to help alleviate postoperative pain in patients following total knee arthroplasty surgery or other limb joint replacement surgeries.Type: GrantFiled: November 19, 2014Date of Patent: January 31, 2017Assignee: SPR THERAPEUTICS, LLCInventors: Joseph W. Boggs, II, Maria E. Bennett, Amorn Wongsarnpigoon, John Chae, Warren M. Grill, Kathryn Stager, Rosemary Zang
-
Patent number: 9381343Abstract: Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.Type: GrantFiled: November 10, 2014Date of Patent: July 5, 2016Assignee: SPR THERAPEUTICS, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, John Chae
-
Patent number: 9248289Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: GrantFiled: July 21, 2014Date of Patent: February 2, 2016Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae
-
Patent number: 8965516Abstract: It has been discovered that pain felt in a given region of the body can be treated by stimulating a peripheral nerve at a therapeutically effective distance from the region where pain is felt to generate a comfortable sensation (i.e., paresthesia) overlapping the regions of pain. A method has been developed to reduce pain in a painful region following limb joint replacement by stimulating a peripheral nerve innervating the painful region with an electrode inserted into tissue and spaced from the peripheral nerve. This method may be used to help alleviate postoperative pain in patients following total knee arthroplasty surgery or other limb joint replacement surgeries.Type: GrantFiled: March 8, 2013Date of Patent: February 24, 2015Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, Amorn Wongsarnpigoon, John Chae, Warren P. Grill, Kathryn Stager, Rosemary Zang
-
Patent number: 8886337Abstract: Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.Type: GrantFiled: December 5, 2011Date of Patent: November 11, 2014Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, John Chae
-
Patent number: 8788046Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: GrantFiled: December 1, 2011Date of Patent: July 22, 2014Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae
-
Patent number: 8788048Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: GrantFiled: December 1, 2011Date of Patent: July 22, 2014Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae
-
Patent number: 8788047Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: GrantFiled: December 1, 2011Date of Patent: July 22, 2014Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae
-
Publication number: 20140121741Abstract: Systems and methods are adapted to provide the relief of pain. The systems and methods make possible the percutaneous placement of one or more intramuscular leads, without the need for fluoroscopy, for providing electrical stimulation to activate a motor point innervating the muscle, to provide the therapeutic relief of pain. The one or more intramuscular leads may be placed in muscle(s) to resist migration. The target nerves and their motor points innervate the muscles in which the one or more leads are placed. The systems and methods can include a two-stage solution. The first stage may include temporary systems and methods, including the use of an external pulse generator. The second stage may include more permanent systems and methods, including the use of an implanted pulse generator.Type: ApplicationFiled: January 6, 2014Publication date: May 1, 2014Applicant: SPR Therapeutics, LLCInventors: Maria E. Bennett, Geoffrey B. Thrope, Joseph W. Boggs, III, Andreas Inmann
-
Publication number: 20140046416Abstract: Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.Type: ApplicationFiled: December 5, 2011Publication date: February 13, 2014Applicant: SPR Therapeutics, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, John Chae
-
Patent number: 8626302Abstract: Systems and methods are adapted to provide the relief of pain. The systems and methods make possible the percutaneous placement of one or more intramuscular leads, without the need for fluoroscopy, for providing electrical stimulation to activate a motor point innervating the muscle, to provide the therapeutic relief of pain. The one or more intramuscular leads may be placed in muscle(s) to resist migration. The target nerves and their motor points innervate the muscles in which the one or more leads are placed. The systems and methods can include a two-stage solution. The first stage may include temporary systems and methods, including the use of an external pulse generator. The second stage may include more permanent systems and methods, including the use of an implanted pulse generator.Type: GrantFiled: August 3, 2009Date of Patent: January 7, 2014Assignee: SPR Therapeutics, LLCInventors: Maria E. Bennett, Geoffrey B. Thrope, Joseph W. Boggs, II, Andreas Inmann, John Chae
-
Publication number: 20130253605Abstract: It has been discovered that pain felt in a given region of the body can be treated by stimulating a peripheral nerve at a therapeutically effective distance from the region where pain is felt to generate a comfortable sensation (i.e., paresthesia) overlapping the regions of pain. A method has been developed to reduce pain in a painful region following limb joint replacement by stimulating a peripheral nerve innervating the painful region with an electrode inserted into tissue and spaced from the peripheral nerve. This method may be used to help alleviate postoperative pain in patients following total knee arthroplasty surgery or other limb joint replacement surgeries.Type: ApplicationFiled: March 8, 2013Publication date: September 26, 2013Applicant: SPR THERAPEUTICS, LLCInventors: Maria E. Bennett, Joseph W. Boggs, Amorn Wongsarnpigoon, John Chae, Warren P. Grill, Kathryn Stager, Rosemary Zang
-
Publication number: 20130238066Abstract: Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt, such as in a case of post-amputation residual limb pain, or purportedly felt in the case of post-amputation phantom limb pain.Type: ApplicationFiled: September 6, 2012Publication date: September 12, 2013Applicant: SPR THERAPEUTICS, LLCInventors: Joseph W. BOGGS, II, Rosemary H. ZANG
-
Publication number: 20120310301Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: ApplicationFiled: December 1, 2011Publication date: December 6, 2012Applicant: SPR THERAPEUTICS, LLCInventors: MARIA E. BENNETT, JOSEPH W. BOGGS, II, WARREN M. GRILL, JOHN CHAE
-
Publication number: 20120310302Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.Type: ApplicationFiled: December 1, 2011Publication date: December 6, 2012Applicant: SPR THERAPEUTICS, LLCInventors: Maria E. Bennett, Joseph W. Boggs, II, Warren M. Grill, John Chae